272. 進行性骨化性線維異形成症 Fibrodysplasia ossificans progressiva Clinical trials / Disease details

臨床試験数 : 40 / 薬物数 : 36 - (DrugBank : 6) / 標的遺伝子数 : 27 - 標的パスウェイ数 : 95

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04307953 (ClinicalTrials.gov)	August 5, 2020	11/3/2020	Saracatinib Trial TO Prevent FOP	Saracatinib Trial TO Prevent FOP	Fibrodysplasia Ossificans Progressiva	Drug: AZD0530 Difumarate;Drug: Matching placebo	VU University Medical Center	Royal National Orthopaedic Hospital NHS Trust;Klinikum Garmisch-Patenkirchen;University of Oxford;Br ...	Recruiting	18 Years	65 Years	All	20	Phase 2	Germany;Netherlands;United Kingdom
2	EUCTR2019-003324-20-NL (EUCTR)	08/01/2020	16/10/2019	A clinical trial to judge the safety, tolerability and effects on abnormal bone formation of reseach ...	Saracatinib trial TO Prevent FOP - STOPFOP	Fibrodyplasia Ossificans Progressiva (FOP) MedDRA version: 20.0;Level: PT;Classification code 100687 ...	Product Name: Saracatinib Product Code: AZD0530 INN or Proposed INN: Saracatinib Other descriptive name ...	VU University Medical Center	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	20	Phase 2	Netherlands

First Previous1Next Last